Dr. Lal PathLabs Limited (BOM:539524)
India · Delayed Price · Currency is INR 1,399.70
-34.80 (-2.43%)
At close: Feb 13, 2026
Dr. Lal PathLabs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 4,871 | 3,577 | 2,388 | 3,448 | 2,916 |
Depreciation & Amortization | 1,344 | 1,368 | 1,430 | 1,008 | 701.25 |
Other Amortization | 75.29 | 68.25 | 72.26 | 73.35 | 70.73 |
Loss (Gain) From Sale of Assets | 21.51 | 2.18 | -8.07 | 6 | 1.74 |
Loss (Gain) From Sale of Investments | -209.3 | -103.97 | -64.21 | -31.62 | -47.29 |
Stock-Based Compensation | 270.95 | 217.06 | 228.11 | 323.09 | 203.74 |
Provision & Write-off of Bad Debts | 45.73 | 7.18 | 112.36 | -6.96 | 51.26 |
Other Operating Activities | -790.79 | -139.82 | 46.92 | -185.91 | -282.85 |
Change in Accounts Receivable | -152.92 | -72.96 | 33.35 | -179.98 | -204.39 |
Change in Inventory | 11.75 | -35.01 | 187.35 | -99.83 | 144.02 |
Change in Accounts Payable | 122.82 | 304.67 | 92.27 | 34.33 | 269.2 |
Change in Other Net Operating Assets | 78.5 | 160.69 | 41.78 | 78.42 | 157.88 |
Operating Cash Flow | 5,689 | 5,353 | 4,560 | 4,467 | 3,982 |
Operating Cash Flow Growth | 6.27% | 17.39% | 2.09% | 12.19% | 40.25% |
Capital Expenditures | -442.94 | -511.67 | -365.15 | -941.06 | -355.64 |
Sale of Property, Plant & Equipment | 6.74 | 8.76 | 5.03 | 16.47 | 4.16 |
Cash Acquisitions | - | -3.54 | -178.19 | -4,576 | -31.5 |
Sale (Purchase) of Intangibles | -95.8 | -62.67 | -80.51 | -3,820 | -240.26 |
Investment in Securities | -3,166 | -147.05 | -2,561 | 4,332 | -1,893 |
Other Investing Activities | 665.9 | 473.48 | 306.26 | 496.29 | 396.18 |
Investing Cash Flow | -3,032 | -242.69 | -2,873 | -4,492 | -2,120 |
Long-Term Debt Issued | - | - | - | 3,454 | - |
Long-Term Debt Repaid | -1,171 | -1,868 | -1,432 | -620.57 | -235.27 |
Total Debt Repaid | -1,171 | -1,868 | -1,432 | -620.57 | -235.27 |
Net Debt Issued (Repaid) | -1,171 | -1,868 | -1,432 | 2,834 | -235.27 |
Issuance of Common Stock | 127.04 | 34.88 | 8.72 | 1.38 | 1.49 |
Common Dividends Paid | -1,999 | -1,995 | -994.13 | -1,167 | -994.83 |
Dividends Paid | -1,999 | -1,995 | -994.13 | -1,167 | -994.83 |
Other Financing Activities | -297.17 | -310.59 | -414.66 | -303.93 | -158.45 |
Financing Cash Flow | -3,340 | -4,139 | -2,832 | 1,365 | -1,386 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.01 | - |
Net Cash Flow | -683.07 | 972.02 | -1,145 | 1,339 | 475.78 |
Free Cash Flow | 5,246 | 4,842 | 4,195 | 3,526 | 3,626 |
Free Cash Flow Growth | 8.35% | 15.41% | 18.98% | -2.76% | 53.14% |
Free Cash Flow Margin | 21.31% | 21.74% | 20.80% | 16.89% | 22.93% |
Free Cash Flow Per Share | 31.44 | 29.08 | 25.24 | 21.25 | 21.91 |
Cash Interest Paid | 223.05 | 293.59 | 377.23 | 303.93 | 158.44 |
Cash Income Tax Paid | 1,639 | 1,320 | 1,064 | 1,300 | 1,017 |
Levered Free Cash Flow | 4,633 | 4,129 | 3,428 | -637.38 | 2,958 |
Unlevered Free Cash Flow | 4,773 | 4,312 | 3,663 | -448.82 | 3,058 |
Change in Working Capital | 60.15 | 357.39 | 354.75 | -167.06 | 366.71 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.